Home › Therapeutic areas › Neurology › Migraine

Migraine (4 companies)

Companies with an active program in Migraine.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
AXSM Axsome Therapeutics Neurology Rare 1 Approved $7.15B 15
ENTA Enanta Pharmaceuticals DermatologyImmunology+2 1 Approved $253M 8
EVMN Evommune DermatologyImmunology+1 1 Phase 2 $290M 6
RAPP Rapport Therapeutics Neurology 1 Phase 3 $1.41B 6